Related Experiment Video
Updated: Sep 15, 2025

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application
Published on: June 8, 2016
Local Hemostatic and Wound-Healing Agent in a Liquid Dosage Form
T G Khonina1,2, S G Alekseenko3, M N Dobrinskaya4
1I. Ya. Postovsky Institute of Organic Synthesis, Ural Branch of the Russian Academy of Sciences, Ekaterinburg, Russia. khonina@ios.uran.ru.
This study introduces a novel liquid hemostatic and wound-healing agent. The non-toxic formulation demonstrates high efficacy in stopping bleeding and promoting tissue repair.
Area of Science:
- Biomaterials Science
- Wound Healing Research
- Hemostasis Agents
Background:
- Effective local hemostatic and wound-healing agents are crucial for managing injuries.
- Current treatments may have limitations in efficacy or safety.
- Development of novel formulations with combined hemostatic and regenerative properties is needed.
Purpose of the Study:
- To develop and characterize a novel liquid colloidal suspension as a combined hemostatic and wound-healing agent.
- To evaluate the hemostatic activity and wound-healing properties of the proposed composition.
Main Methods:
- Formulation of a water-glycerol colloidal suspension.
- Inclusion of active substances: silicon and iron glycerolates, and chitosan.
- Addition of polyvinylpyrrolidone as an auxiliary substance.
- Assessment of non-toxicity, hemostatic activity at varying iron concentrations, and wound-healing properties.
Main Results:
- The proposed agent is a non-toxic liquid colloidal suspension.
- High hemostatic activity was observed, consistent across different concentrations of iron (III) monoglycerolate (0.40 and 0.80 wt%).
- The formulation exhibited pronounced wound-healing properties.
Conclusions:
- The developed liquid agent effectively combines hemostatic and wound-healing capabilities.
- The formulation shows promise as a safe and efficient therapeutic option for wound management.
- Further research can explore clinical applications of this novel biomaterial.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Clot Retraction and Fibrinolysis

